Search

Rabia Fatima (McMaster University) and colleagues have published a new review on phage-antibiotic synergy against Pseudomonas, synthesizing clinical successes and the mechanisms behind them while underscoring the tenuous links between curre

Is passion enough for to keep our industry going? Jennifer Leeds (ex-Novartis; one of the microbiologists who had to help shut down Novartis’ infectious disease department) published a new perspective on antibiotic R&D talent drain, sharing

Michael Doud (University of California, San Diego) and colleagues published a new paper on AI applications in phage therapy, showing how AI can improve phage-host matching, discover novel phage genes, and guide development of synthetic ther

Bradley Cook (Cytophage Technologies) and Alexander Hynes (McMaster University) published a new paper on re-evaluating phage therapy criteria. They examine three commonly applied criteria for excluding phages from therapy: the lack of virul

Sabrina Green (KU Leuven) wrote a great perspective piece for Nature Microbiology on communicating the promise of phage therapy, her tips on how best to use social media (when memes? when papers?) to get more people to understand its promis

Jeremy Barr (Monash University) published a new perspective on T-series phages as reductionist models, discussing how these phages have shaped the field of microbiology and continue to be important research tools.

Sandra Morales and Paul Hyman have published a new perspective called "Quis Custodiet? Are Regulations Slowing Phage Therapy?".  In it, they discuss current regulations, recent efficacy trials and support resources in the context of regulat

Lorenz Leitner and Shawna McCallin (Balgrist University Hospital) published a new paper on guiding phage therapy with genomic surveillance, showing how integrating global and local genomic data can inform phage cocktail design for a middle

Is the Nagoya Protocol doing its job to ensure countries get the benefits from their own genetic resources? Hassan Salem & Martin Kaltenpoth (Max Planck Institute) argue that the protocol's implementation has impeded research due to incompa

In a recent perspective piece, Christine Szymanski (University of Georgia) highlights the limitless resources for exploitation that phages provide. She discusses their use in various fields such as phage therapy, gene transduction, and glyc

Jean-Paul Pirnay and colleagues explore the question of whether magistral phage preparations could serve as a model for everyone.

Lene Bens (KU Leuven, Belgium) and colleagues published a perspective on phage therapy for Hidradenitis Suppurativa, highlighting the unique challenge and opportunity for personalized treatment of a complex, inflammatory disease.

In this JAMA Medical News & Perspectives article, Eli Cahan discusses the resurgence of interest in phage therapy in the wake of the COVID-19 pandemic.

Joshua D Jones (University of Edinburgh) and colleagues authored a new perspective on why patients should not be transferred between healthcare jurisdictions for phage therapy in the UK.

Olivier Zablocki shares an updated ecosystem of microbiome/virome apps and guides (iVirus 2), which are freely available to run on CyVerse & DOE KBase. Learn more with their new perspective piece.

New perspectives on the therapeutic role of phages and emerging knowledge on their role in the gut microbiota.

Daniel Gelman (Hebrew University of Jerusalem) and colleagues published a new paper in The Lancet Microbe entitled Clinical Phage Microbiology: a suggested framework and recommendations for the in-vitro matching steps of phage therapy. This

Lorenz Leitner (Balgrist University Hospital, University of Zürich) and colleagues published a new paper in Spinal Cord on the potential role of phages in prolonging life after spinal cord injury.

Martin Loessner and Rob Lavigne co-edited a special issue of Current Opinion in Biotechnology dedicated to phage, entitled Nanobiotechnology — Phage Therapy. The issue is now complete: check out the 21 articles here!

Ali Khalid (Westmead Institute of Medical Research) and colleagues published a new paper in Frontiers in Microbiology entitled A Phage Therapy Guide for Clinicians and Basic Scientists: Background and Highlighting Applications for Developin